{"Symbol": "INCY", "AssetType": "Common Stock", "Name": "Incyte Corporation", "Description": "Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.", "CIK": "879169", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, UNITED STATES, 19803", "OfficialSite": "https://www.incyte.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-12-31", "MarketCapitalization": "20120363000", "EBITDA": "1439770000", "PERatio": "15.77", "PEGRatio": "0.135", "BookValue": "26.04", "DividendPerShare": "None", "DividendYield": "None", "EPS": "6.41", "RevenuePerShareTTM": "26.34", "ProfitMargin": "0.25", "OperatingMarginTTM": "0.256", "ReturnOnAssetsTTM": "0.136", "ReturnOnEquityTTM": "0.299", "RevenueTTM": "5141242000", "GrossProfitTTM": "2718960000", "DilutedEPSTTM": "6.41", "QuarterlyEarningsGrowthYOY": "0.436", "QuarterlyRevenueGrowthYOY": "0.278", "AnalystTargetPrice": "107.05", "AnalystRatingStrongBuy": "2", "AnalystRatingBuy": "9", "AnalystRatingHold": "12", "AnalystRatingSell": "2", "AnalystRatingStrongSell": "0", "TrailingPE": "15.77", "ForwardPE": "13.07", "PriceToSalesRatioTTM": "3.913", "PriceToBookRatio": "3.894", "EVToRevenue": "3.225", "EVToEBITDA": "9.42", "Beta": "0.847", "52WeekHigh": "112.29", "52WeekLow": "53.56", "50DayMovingAverage": "101.71", "200DayMovingAverage": "85.55", "SharesOutstanding": "199014000", "SharesFloat": "166949000", "PercentInsiders": "1.871", "PercentInstitutions": "105.334", "DividendDate": "None", "ExDividendDate": "None"}